Title : Vandetanib: An overview of its clinical development in NSCLC and other tumors.

Pub. Date : 2010 Sep

PMID : 20967300






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Vandetanib is an oral inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2), epidermal growth factor receptor (EGFR) and Ret tyrosine kinases involved in tumor growth, progression and angiogenesis. vandetanib kinase insert domain receptor Homo sapiens
2 Vandetanib is an oral inhibitor of vascular endothelial growth factor receptor 2 (VEGFR-2), epidermal growth factor receptor (EGFR) and Ret tyrosine kinases involved in tumor growth, progression and angiogenesis. vandetanib kinase insert domain receptor Homo sapiens